The Use of MEK Inhibitors in Neurofibromatosis Type 1-Associated Tumors and Management of Toxicities

导出原文传递

翻译打印收藏纠错

作者： Klesse, Laura J. ^[1] ; Jordan, Justin T. ^[2] ; Radtke, Heather B. ^[3] ; Rosser, Tena ^[4] ; Schorry, Elizabeth ^[5] ; Ullrich, Nicole ^[6] ; Viskochil, David ^[7] ; Knight, Pamela ^[8] ; Plotkin, Scott R. ^[9] ; Yohay, Kaleb

作者单位： USC, Childrens Hosp Los Angeles, Keck Sch Med, Los Angeles, CA USA ^[1] Univ Cincinnati, Cincinnati Childrens Hosp, Cincinnati, OH USA ^[2] Univ Wisconsin, Madison, WI USA ^[3] NYU Langone Hlth, 222 East 41st St, New York, NY 10017 USA ^[4] Massachusetts Gen Hosp, Boston, MA 02114 USA ^[5] Childrens Tumor Fdn, New York, NY USA ^[6] Boston Childrens Hosp, Dana Farber Canc Inst, Boston, MA USA ^[7] Univ Texas Southwestern, Dallas, TX USA ^[8] Univ Utah, Salt Lake City, UT USA ^[9]

关键词 Neurofibromatosis type 1 MEK inhibitor Plexiform neurofibroma

发布时间 2020-12-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交